** = Publications listed in SCI/SSCI/Pubmed
** Gerger, A; Langsenlehner, U; Renner, W; Weitzer, W; Eder, T; Yazdani-Biuki, B; Hofmann, G; Samonigg, H; Krippl, P
A multigenic approach to predict breast cancer risk.
Breast Cancer Res Treat. 2007; 104(2):159-164
Doi: 10.1007/s10549-006-9408-4
Web of Science
PubMed
FullText
FullText_MUG
** Hofmann, G; Gerger, A; Weitzer, W; Langsenlehner, T; Fuerst, F; Renner, W; Samonigg, H; Krippl, P; Langsenlehner, U
The ITGA2 807C > T polymorphism is associated with reduced colorectal cancer susceptibility
ANN ONCOL. 2007; 18: VII38-VII38.-2007 World Congress on Gastrointestinal Cancer; JUN 27-30, 2007; Barcelona, SPAIN.
[Poster]
Web of Science
** Langsenlehner, U; Gerger, A; Weitzer, W; Krippl, P
COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic for molecular markers.
Breast Cancer Res Treat. 2007; 101(2): 247-247.
Doi: 10.1007/s10549-006-9291-z
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Yazdani-Biuki, B; Eder, T; Renner, W; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H; Krippl, P
The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
Clin Cancer Res. 2006; 12(4):1392-1394
Doi: 10.1158/1078-0432.CCR-05-2055
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bauernhofer, T; Samonigg, H; Regitnik, P; Lileg, B; Weizer, W; Waxenecker, G; Kainer, M; Wiederkum, S; Loibner, H; Kircheis, R
A phase I/II, open label trial of Lewis Y specific monoclonal antibody IGN311 to evaluate safety and efficacy in patients with malignant effusion.
J CLIN ONCOL. 24(18):111S-111S.-Asco-Meetung; 2.-6. Juni 2006; Atlanta/ Georgia, USA.
[Poster]
Web of Science
** Loibner, H; Bauernhofer, T; Samonigg, H; Regitnig, P; Weitzer, W; Lileg, B; Waxenecker, G; Kainer, M; Wiederkum, S; Schuster, M; Kircheis, R
A phase I/II, open label trial with the Lewis Y specific humanized monoclonal antibody IGN311 in patients with malignant effusions
J IMMUNOTHER. 29(6):634-634.-Meeting Society of Immunotherapy, 21st annual meeting; 26.-29. Oktober 2006; Los Angeles, USA.
[Poster]
Web of Science
** Langsenlehner, U; Eder, T; Weitzer, W; Samonigg, H; Krippl, P
The most common integrin ITGA2 haplotype (807C_1648G, wildtype) is associated with decreased breast cancer risk
BREAST CANCER RES TREAT 2005 94: -.
Web of Science
** Langsenlehner, U; Krippl, P; Eder, T; Weitzer, W; Samonigg, H
Interleukin-10 TCATA haplotype is associated with decreased breast cancer risk
ANN ONCOL 2005 16: 271-271.
Web of Science
** Vrecl, R; Gerold, M; Melzer, S; Rainer, W; Weitzer, W
Effect of capecitabine on mean corpuscular volume of red blood cells.
Am J Clin Oncol. 2005; 28(5):534-534
Doi: 10.1097/01.coc.0000173186.49719.b1
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Eder, T; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H
Genetic variants of the sulfotransferase 1A1 and breast cancer risk.
Breast Cancer Res Treat. 2004; 87(1):19-22
Doi: 10.1023/B:BREA.0000041574.90735.ea
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
** Krippl, P; Langsenlehner, U; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Leithner, A; Samonigg, H
The 870G>A polymorphism of the cyclin D1 gene is not associated with breast cancer.
Breast Cancer Res Treat. 2003; 82(3):165-168
Doi: 10.1023/B:BREA.0000004372.20461.33
Web of Science
PubMed
FullText
FullText_MUG
** Langsenlehner, U; Krippl, P; Renner, W; Yazdani-Biuki, B; Wolf, G; Wascher, TC; Paulweber, B; Weitzer, W; Samonigg, H
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
Breast Cancer Res Treat. 2003; 81(2):169-172
Doi: 10.1023/A:1025752420309
Web of Science
PubMed
FullText
FullText_MUG